JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial

  • 0Hôpital St-Antoine and Université Pierre et Marie Curie, Paris, France.
Gastroenterology +

|

May 7, 2013

|

May 7, 2013

Related Experiment Videos

Contact us if these videos are not relevant.

View abstract on PubMed

Summary

This summary is machine-generated.

Early azathioprine treatment for Crohn's disease (CD) did not improve clinical remission rates compared to conventional management. This study found no significant difference in time spent in remission for early versus delayed immunosuppressant use in CD patients.

Area Of Science

  • Gastroenterology
  • Immunology
  • Clinical Trials

Background

  • Immunomodulator therapy is effective for Crohn's disease (CD) but its impact on disease progression is unclear.
  • Early intervention may be crucial, as current treatments are often initiated late in the disease course.

Purpose Of The Study

  • To compare the efficacy of early azathioprine treatment (within 6 months of diagnosis) versus conventional management in high-risk CD patients.
  • To assess the impact of early immunosuppression on disease progression and remission rates.

Main Methods

  • An open-label, randomized trial involving 132 adult CD patients diagnosed within 6 months.
  • Patients were assigned to early azathioprine (n=65) or conventional management (n=67) for 3 years.
  • The primary endpoint was the proportion of time spent in corticosteroid-free and anti-TNF-free remission.

Main Results

  • No significant difference in the median percentage of time in remission between the azathioprine group (67%) and conventional management group (56%) (P = .69).
  • A higher proportion of patients in the azathioprine group remained free of perianal surgery (96% vs. 82%, P = .036).
  • No difference in the cumulative proportion of patients free of intestinal surgery or anti-TNF therapy.

Conclusions

  • Early administration of azathioprine within 6 months of CD diagnosis did not improve clinical remission rates compared to conventional management.
  • Early immunosuppression showed a benefit in reducing perianal surgery rates.
  • Further research may be needed to identify optimal early treatment strategies for high-risk Crohn's disease patients.

Keywords:

Related Experiment Videos

Contact us if these videos are not relevant.

Related Concept Videos